By Megan Martin, Communications Manager
Through NCCN Academy for Excellence & Leadership in Oncology™, a new educational offering from the National Comprehensive Cancer Network (NCCN), pharmaceutical and biotech professionals are hearing perspectives from oncologists, cancer program administrators, oncology pharmacy directors, and national managed care payors.
“With constant changes to both the clinical aspects and policy impacting the practice of oncology, clinicians are calling for business professionals to be well-versed in relevant information beyond the products they represent,” said William T. McGivney, PhD, Chief Executive Officer, NCCN. “As an authoritative source in oncology care, NCCN is pleased to offer robust, educational programs through NCCN Academy that can help professionals integrate key advances and marketplace changes into their business operations and decisions.”
The School of Pharmaceutical & Biotech Business is the first in the NCCN Academy for Excellence & Leadership in Oncology™ series of oncology certificate programs designed by NCCN to improve the working knowledge of key business, policy, coverage, clinical, reimbursement, informational, and operational issues in oncology and gather valuable insights for developing effective strategies for navigating the various constituencies in cancer care.
The School of Pharmaceutical & Biotech Business program features an interactive curriculum that exposes participants to the current environment, trends, and controversies facing the oncology sector and discussion about how key stakeholders, including industry, can create mutually successful working relationships. The scope of the subject matter is far reaching and ranges from the science and business of oncology; to the future of oral chemotherapy and biologics; to frank discussions about cancer policy, coverage and reimbursement, and working effectively with key decision makers.
NCCN Academy offers an introductory curriculum as well as an advanced program. A program delivered in July 2009 in San Francisco, CA with more than 75 participants was geared towards an experienced audience seeking advanced and in-depth information. The next NCCN Academy program, scheduled for October 14 and 15, 2009 in Chicago, IL will likewise target experienced biotech and pharmaceutical professionals from marketing, sales, medical affairs, clinical research, policy and government affairs, and other business areas.
Recent reports show that physicians find considerable value in meeting with industry representatives whose knowledge goes beyond product information, making for a more substantive, credible discussion. The School of Pharmaceutical & Biotech Business provides a casual and open learning atmosphere to help professionals better understand the impact of information on data and decisions that influence the availability and use of drugs and biologics in cancer care.
Enrollment is currently open for the west coast session of NCCN Academy for Excellence & Leadership in Oncology™ School of Pharmaceutical & Biotech Business scheduled for October 14 – 15, 2009 in Chicago, IL. Click here for complete registration information and a program syllabus.
Additional Schools within NCCN Academy for Excellence & Leadership in Oncology™ will include programs for cancer center administrators, clinical executive leaders, and oncology fellows in addition to pharmaceutical and biotech professionals.